Paracel Explorer

Dernière publication·Octobre 2026

Vosevi

Sofosbuvirum / Velpatasvirum / Voxilaprevirum — cpr pell 400/100/100

Gilead Sciences Switzerland Sàrl

Swissmedic66510

Dossier20725

Remboursement

QP 10%

Modifications (5)